Neonatal Care in Low- and Middle-Income Countries: A Fresh Look.

Neonatology

Institute for Global Health and Development, The Aga Khan University, Karachi, Pakistan.

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11875412PMC
http://dx.doi.org/10.1159/000543956DOI Listing

Publication Analysis

Top Keywords

neonatal care
4
care low-
4
low- middle-income
4
middle-income countries
4
countries fresh
4
neonatal
1
low-
1
middle-income
1
countries
1
fresh
1

Similar Publications

Objective: To compare maternal and neonatal adverse outcomes between women who are English proficient (EP) and those who have limited English proficiency (LEP).

Design: Retrospective cohort study.

Setting: Single US academic medical centre with interpreter services.

View Article and Find Full Text PDF

A common problem among preterm newborns is extrauterine growth restriction, or EUGR. The Evidence-based Practice for Improving Quality (EPIQ) strategy aims to reduce EUGR and enhance growth outcomes in neonatal intensive care units (NICUs). The objective of this study is to assess whether implementing EPIQ-based quality improvement interventions is associated with reduced EUGR among preterm infants (< 34 weeks gestation) in a before-after observational study.

View Article and Find Full Text PDF

Impact of chorionic villus sampling volume on time to result and pregnancy management.

J Matern Fetal Neonatal Med

December 2025

Section of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.

Objective: To evaluate the association between low-volume chorionic villus sampling (CVS) and delay in patient care.

Methods: This is a retrospective cohort study of patients who underwent CVS from 8/19/2019 to 12/31/2022 in a single center. The exposure was low-volume CVS, defined as less than 15 mg of sample.

View Article and Find Full Text PDF

Recent improvements in cell-free DNA technology have enabled non-invasive prenatal testing (NIPT) to screen for fetal single-gene autosomal recessive conditions from maternal blood as early as the first trimester. This technique can determine the fetal risk for cystic fibrosis (CF) with a single blood sample from a pregnant person without the need for a partner sample, which is required for traditional carrier screening. A retrospective review of 100,106 consecutive general-risk pregnant patients who underwent CF carrier screening was completed.

View Article and Find Full Text PDF